Resumen de Fat Attack.
The article discusses the review of 3 antiobesity drugs by the U.S. Food and Drug Administration (FDA) for government approval and concern regarding health risks associated with the use of such drugs. The article notes that of the many uses of therapeutic drugs, those developed and used to fight obesity have had the most failures. Examples are noted. Certain researchers reportedly believe that antiobesity drug use presents lower risks to patients than gastric bypass surgery. The status of development of antiobesity drugs is likened to that of beta blockers developed in the 1960s, before which, surgical means were used to treat hypertension.
